Form 8-K - Current report:
SEC Accession No. 0001213900-22-077304
Filing Date
2022-12-02
Accepted
2022-12-02 16:10:25
Documents
13
Period of Report
2022-12-01
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea169585-8k_chinapharma.htm   iXBRL 8-K 41205
2 PRESS RELEASE DATED DECEMBER 2, 2022, ANNOUNCING THE RECEIPT OF NOTICE OF NONCOM ea169585ex99-1_chinapharma.htm EX-99.1 9805
  Complete submission text file 0001213900-22-077304.txt   228695

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cphi-20221201.xsd EX-101.SCH 3260
4 XBRL LABEL FILE cphi-20221201_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE cphi-20221201_pre.xml EX-101.PRE 22381
7 EXTRACTED XBRL INSTANCE DOCUMENT ea169585-8k_chinapharma_htm.xml XML 3585
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

EIN.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34471 | Film No.: 221442039
SIC: 2834 Pharmaceutical Preparations